克拉玛依市35~75岁体检人群高血压、糖尿病、血脂异常调查

doi:10.19485/j.cnki.issn2096-5087.2022.03.004

预防医学

2022, Vol. 34

Issue (3): 232-239 DOI: 10.19485/j.cnki.issn2096-5087.2022.03.004

论著

本期目录 | 过刊浏览 | 高级检索

克拉玛依市35~75岁体检人群高血压、糖尿病、血脂异常调查

郑帅印¹, 李富业¹, 谢尔瓦妮古丽·阿卜力米提¹, 李砥²

1.新疆医科大学公共卫生学院,新疆乌鲁木齐 830011;
2.克拉玛依市中心医院临床医学研究中心,新疆克拉玛依 834000

Prevalence of hypertension, diabetes and dyslipidemia among physical examination populations at ages of 35 to 75 years in Karamay City

ZHENG Shuaiyin¹, LI Fuye¹, Xieerwaniguli Abulimiti¹, LI Di²

1. School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang 830011, China;
2. Karamay Central Hospital Clinical Medicine Research Center, Karamay, Xinjiang 834000, China

摘要
参考文献
相关文章
Metrics

全文: PDF(837 KB)
输出: BibTeX | EndNote (RIS)

摘要目的了解新疆维吾尔自治区克拉玛依市35~75岁体检人群高血压、糖尿病和血脂异常情况,为相关慢性病防治提供依据。方法采用整群随机抽样方法抽取克拉玛依市9个社区35~75岁体检人群为调查对象。通过问卷调查收集人口学和健康相关行为资料,测量身高、体重和血压,检测空腹血糖、血脂等指标。描述性分析高血压、糖尿病和血脂异常的患病情况,并采用多因素logistic回归模型分析影响因素。结果共调查32 556人,年龄为（56.63±12.78）岁。其中男性12 354人占37.95%,女性20 202人占62.05%。高血压、糖尿病和血脂异常检出率分别为31.72%、12.18%和28.69%。常见的共病组合为高血压合并血脂异常,2 483例占7.63%。多因素logistic回归分析结果显示,男性（OR=1.362、1.823、1.130）、≥40岁（OR：3.327~14.019、2.870~15.337、1.530~2.092）、有慢性病家族史（OR=1.147、1.249、1.200）、吸烟（OR=1.111、1.464、1.248）、荤食为主（OR=2.081、2.266、1.110）、素食为主（OR=0.479、0.353、0.634）、体重过低（OR=0.504、0.298、0.546）、超重（OR=1.872、1.565、1.289）和肥胖（OR=2.840、2.177、1.230）是高血压、糖尿病和血脂异常共同的影响因素。结论克拉玛依市35~75岁体检人群高血压患病率较高,性别、年龄、慢性病家族史、吸烟、饮食习惯和BMI是高血压、糖尿病和血脂异常的共同影响因素。

	服务

	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	郑帅印
	李富业
	谢尔瓦妮古丽·阿卜力米提
	李砥

关键词 ：高血压, 糖尿病, 血脂异常, 体检人群

Abstract：Objective To investigate the prevalence of hypertension, diabetes and dyslipidemia among physical examination populations at ages of 35 to 75 years in Karamay City of Xinjiang Uygur Autonomous Region, so as to provide insights into the management of chronic disease control. Methods Residents receiving physical examinations at ages of 35 to 75 years were sampled from 9 communities in Karamay City using the cluster random sampling method. Demographic features and health-related behaviors were collected using questionnaires, and the height, weight, blood pressure, and fasting blood glucose and blood lipid levels were measured. The prevalence of hypertension, diabetes and dyslipidemia was descriptively analyzed, and their risk factors were identified using multivariable logistic regression analysis. Results A total of 32 556 subjects were sampled, including 12 354 males ( 37.95% ) and 20 202 females ( 62.05% ), with a mean age of ( 56.63±12.78 ) years. The prevalence of hypertension, diabetes and dyslipidemia was 31.72%, 12.18% and 28.69%, and the common comorbidity was dyslipidemia with hypertension ( 2 483 cases, 7.63% ). Multivariable logistic regression analysis identified men ( OR=1.362, 1.823 and 1.130 ), ages of ≥40 years ( OR=3.327-14.019, 2.870-15.337 and 1.530-2.092 ), a family history of chronic diseases ( OR=1.147, 1.249 and 1.200 ), smoking ( OR=1.111, 1.464 and 1.248 ), meat-based diet ( OR=2.081, 2.266 and 1.110 ), vegetable-based diet ( OR=0.479, 0.353 and 0.634 ), underweight ( OR=0.504, 0.298 and 0.546 ), overweight ( OR=1.872, 1.565 and 1.289 ) and obesity ( OR=2.840, 2.177 and 1.230 ) as common influencing factors for hypertension, diabetes and dyslipidemia. Conclusions The prevalence of hypertension is high among physical examination populations at ages of 35 to 75 years in Karamay City. Gender, age, a family history of chronic diseases, smoking, diet habits and body mass index are common factors affecting hypertension, diabetes and dyslipidemia.

Key words： hypertension diabetes dyslipidemia physical examination population

收稿日期: 2021-09-24 修回日期: 2022-01-08 出版日期: 2022-03-10

中图分类号:

R195

基金资助:新疆维吾尔自治区自然科学基金面上项目（2021D01A22）; 克拉玛依市创新人才工程（2019RC001A-15）

作者简介: 郑帅印,硕士在读

通信作者: 李砥,E-mail：358477093@qq.com

引用本文:

郑帅印, 李富业, 谢尔瓦妮古丽·阿卜力米提, 李砥. 克拉玛依市35~75岁体检人群高血压、糖尿病、血脂异常调查[J]. 预防医学, 2022, 34(3): 232-239.
ZHENG Shuaiyin, LI Fuye, Xieerwaniguli Abulimiti, LI Di. Prevalence of hypertension, diabetes and dyslipidemia among physical examination populations at ages of 35 to 75 years in Karamay City. Preventive Medicine, 2022, 34(3): 232-239.

链接本文:

https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.03.004 或 https://www.zjyfyxzz.com/CN/Y2022/V34/I3/232

[1] 中华人民共和国国家卫生健康委员会.中国居民营养与慢性病状况报告(2020年)[J].营养学报,2020,42(6):521.
National Health Commission of the People's Republic of China.A report on nutrition and chronic diseases of China(2020)[J].Acta Nutrimenta Sin,2020,42(6):521.
[2] LIU G,LI Y,HU Y,et al.Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus[J].J Am Coll Cardiol,2018,71(25):2867-2876.
[3] 吴海燕,刘延玲,杨德民,等.克拉玛依市社区慢性病四方联动防治模式的探索与实践[J].中国慢性病预防与控制,2015,23(3):219-221.
WU H Y,LIU Y L,YANG D M,et al.Exploration and practice of four party linkage prevention and treatment model of chronic diseases in Karamay community[J].Chin J Prev Control Chron Dis,2015,23(3):219-221.
[4] 克拉玛依市卫生健康委员会.对克拉玛依市八届政协二次会议第S201813号提案的答复函[EB/OL].(2018-09-01)[2022-01-08].https://www.klmy.gov.cn/010/010002/010002022/20190315/33573214-e446-4c59-89d1-03673be28b97.html.
[5] 中华人民共和国国家卫生健康委员会.健康中国行动(2019—2030年)[EB/OL].(2019-07-15)[2022-01-08].http://www.nhc.gov.cn/guihuaxxs/s3585u/201907/e9275fb95d5b4295be8308415 d4cd1b2.shtml.
[6] 中国高血压防治指南修订委员会.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
Writing Group of 2018 Chinese Guidelines for the Management of Hypertension.2018 Chinese guidelines for the management of hypertension of 2018 Chinese Guidelines for the Management of Hypertension.2018 Chinese guidelines for the management of hypertension[J].Chin J Cardiol,2019,24(1):24-56.
[7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
Chinese Diabetes Society.Guidelines for the prevention and control of type 2 diabetes in China(2017 editon)[J].Chin J Pract Intern Med,2018,38(4):292-344.
[8] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华健康管理学杂志,2017,11(1):7-28.
Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults.2016 Chinese guideline for the management of dyslipidemia in adults[J].Chin J Health Manag,2017,11(1):7-28.
[9] 中华人民共和国卫生部.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
Ministry of Health of the People's Republic of China.Guidelines for prevention and control of overweight and obesity in Chinese adults[M].Beijing:People's Medical Publishing House,2006.
[10] 中华医学会健康管理学分会,中华健康管理学杂志编委会.健康体检基本项目专家共识[J].中华健康管理学杂志,2014,8(2):81-90.
Chinese Health Management Society,Editorial Board of Chinese Journal of Health Management.Expert consensus on basic items of physical examination[J].Chin J Health Manag,2014,8(2):81-90.
[11] 苏媛,陈岭,梅卿.社区高血压人群血压分级和体质指数与胰岛素抵抗指数的相关关系[J].中国初级卫生保健,2012,26(4):39-41.
SU Y,CHEN L,MEI Q.The correlations of homeostasis model assessment insulin resistance index with hypertension classification and body mass index among hypertension patients in community[J].Chin Prim Health Care,2012,26(4):39-41.
[12] 吴胜利,朱玉靖,黄丽娟,等.克拉玛依市社区居民慢性病及代谢综合征调查分析[J].新疆医学,2017,47(2):165-168.
WU S L,ZHU Y J,HUANG L J,et al.A survey and analysis of chronic disease and metabolic syndrome for residents in Karamay communities[J].Xinjiang Med J,2017,47(2):165-168.
[13] LIU X,BRAGG F,YANG L,et al.Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women:a 9-year prospective study of 0.5 million people[J].Lancet Public Health,2018,3(4):167-176.
[14] AMBROSE J A,BARUA R S.The pathophysiology of cigarette smoking and cardiovascular disease:an update[J].J Am Heart Assoc,2004,43(10):1731-1737.
[15] ZHANG H,KWAPONG W R,SHAO M M,et al.Predictors of the prevalence of dyslipidemia and influencing factors for young health examination cohort:a cross-sectional survey[J/OL].Front Public Health,2020(2020-09-23)[2022-01-08]. https://doi.org/10.3389/fpubh.2020.00400.
[16] 吴梦怡,胡劲松,黄霜,等.湖南省30岁及以上社区居民高血压、糖尿病、高血脂共病的影响因素分析[J].预防医学,2021,33(2):157-161.
WU M Y,HU J S,HUANG S,et al.Prevalence and comorbidity factors of hypertension,diabetes and hyperlipidemia among community residents aged 30 years or over in Hunan Province[J].Prev Med,2021,33(2):157-161.
[17] FOROUHI N G,MISRA A,MOHAN V,et al.Dietary and nutritional approaches for prevention and management of type 2 diabetes[J/OL].BMJ,2018,361(2018-06-13)[2022-01-08]. https://doi.org/10.1136/bmj.k2234.
[18] 张洁,何青芳,王立新,等.浙江省成年人血脂异常知晓率、治疗率和控制率的影响因素分析[J].预防医学,2020,32(12):1230-1235.
ZHANG J,HE Q F,WANG L X,et al.lnfluencing factors for the awareness,treatment and control rates of dyslipidemia among adults in Zhejiang Province[J].Prev Med,2020,32(12):1230-1235.
[19] PAN X F,WANG L,PAN A.Epidemiology and determinants of obesity in China[J].Lancet Diabetes Endocrinol,2021,9(6):373-392.

[1]	高慧, 谢亮, 姚春阳, 王林红, 金鎏, 胡洁. 血脂异常患者社区综合管理模式的干预效果评价[J]. 预防医学, 2026, 38(1): 15-19.
[2]	吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[3]	郭艳强, 张丽, 张兰, 韩荣荣. 高血压患者肥胖类型与动脉粥样硬化性心血管疾病风险的关系研究[J]. 预防医学, 2026, 38(1): 36-42.
[4]	陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[5]	张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[6]	刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[7]	孟杨, 万金豹, 吴萃, 陈秋艳, 严青华, 程旻娜. 上海市农村高血压患者高血压知信行及家庭血压测量调查[J]. 预防医学, 2025, 37(7): 737-742.
[8]	俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[9]	李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
[10]	陆丽君, 袁磊, 李殿江, 卢昆, 朱怡萱, 王志勇, 刘思浚. 老年2型糖尿病患者自我效能、自我管理行为在抑郁症状与血糖控制间的中介效应分析[J]. 预防医学, 2025, 37(5): 455-459.
[11]	史美琦, 殷玉华, 汪旭虹, 付元庆, 苗泽蕾, 胡文胜. 妊娠糖尿病孕妇植物性饮食模式与孕期体重增加的关联研究[J]. 预防医学, 2025, 37(5): 503-506.
[12]	王英杰综述, 孙高峰, 审校. 2型糖尿病预测模型研究进展[J]. 预防医学, 2025, 37(4): 369-372,377.
[13]	李倩, 杨柏林, 陈积标, 尹寒露, 许祝平, 孟晓军. 无锡市50岁及以上HIV/AIDS抗病毒治疗病例自报慢性病资料分析[J]. 预防医学, 2025, 37(4): 390-394.
[14]	王启开, 弭亚楠, 刘好, 林嘉浩, 杨鑫源, 王越, 金千靖, 宋照猛. 高血压肾病患者膳食干预效果评价[J]. 预防医学, 2025, 37(4): 373-377.
[15]	缪彩云, 覃玉, 万亚男, 陈路路, 崔岚, 王小莉. 江苏省居民自测血压行为及影响因素分析[J]. 预防医学, 2025, 37(3): 223-227.

Viewed

Full text

Abstract

Cited

Shared

Discussed